Category Archives: Crit Rev Oncol Hematol

Early ageing after cytotoxic treatment for testicular cancer and cellular senescence: Time to act.

Early ageing after cytotoxic treatment for testicular cancer and cellular senescence: Time to act.
Crit Rev Oncol Hematol. 2020 May 07;151:102963
Authors: Lubberts S, Meijer C, Demaria M, Gietema JA
Abstrac… Continue reading

Posted in Crit Rev Oncol Hematol | Tagged | Leave a comment

Constitutive NF-κB activation in AML: Causes and treatment strategies.

Related Articles

Constitutive NF-κB activation in AML: Causes and treatment strategies.

Crit Rev Oncol Hematol. 2015 Oct 17;

Authors: Bosman MC, Schuringa JJ,…

Continue reading

Posted in Crit Rev Oncol Hematol | Tagged | Leave a comment

Studying cancer metastasis: Existing models, challenges and future perspectives.

Studying cancer metastasis: Existing models, challenges and future perspectives.

Crit Rev Oncol Hematol. 2015 Aug 10;

Authors: van Marion DM, Domanska UM, Timmer-Bosscha…

Continue reading

Posted in Crit Rev Oncol Hematol | Tagged | Leave a comment

Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus.

Related Articles
Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus.
Crit Rev Oncol Hematol. 2015 Jul 2;
Autho… Continue reading

Posted in Crit Rev Oncol Hematol | Leave a comment

Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus.

Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus.
Crit Rev Oncol Hematol. 2015 Jun 19;
Authors: Schindler A, Denaro N, Russi EG, Pizzorni N,… Continue reading

Posted in Crit Rev Oncol Hematol | Leave a comment

Internet-based support programs to alleviate psychosocial and physical symptoms in cancer patients: A literature analysis.

Internet-based support programs to alleviate psychosocial and physical symptoms in cancer patients: A literature analysis.

Crit Rev Oncol Hematol. 2015 Jan 31;

Authors: Bouma G, Admiraal JM, de Vries EG, Schröder CP, Walenkamp AM, Reyners AK

Abstract
In this review the effect of internet-based support programs on psychosocial and physical symptoms resulting from cancer diagnosis and treatment is analyzed. Selection of studies was based on the following criteria: (non-)randomized controlled trials, performed in adult cancer patients, comparing quantitative psychosocial and/or physical outcomes of an internet-based support program with (a) comparison group(s). Literature search yielded 2032 studies of which 16 fulfilled the eligibility criteria. Three different internet-based support programs were identified: social support groups, online therapy for psychosocial/physical symptoms, and online systems integrating information, support, and coaching services. Outcomes improved by these programs in nine studies. Especially fatigue, social support, and distress improved, regardless of the program type. All online systems showed positive effects, mainly for social support and quality of life. This analysis indicates that internet-based support programs are effective in improving psychosocial and physical symptoms in cancer patients.

PMID: 25701515 [PubMed – as supplied by publisher]

Continue reading

Posted in Crit Rev Oncol Hematol | Leave a comment

Risk analysis, diagnosis and management of gastrointestinal mucositis in pediatric cancer patients.

Risk analysis, diagnosis and management of gastrointestinal mucositis in pediatric cancer patients.
Crit Rev Oncol Hematol. 2014 Dec 19;
Authors: Kuiken NS, Rings EH, Tissing WJ
Abstract
Mucositis is … Continue reading

Posted in Crit Rev Oncol Hematol | Leave a comment

Anti-angiogenic therapy in pediatric brain tumors: an effective strategy?

Related Articles
Anti-angiogenic therapy in pediatric brain tumors: an effective strategy?
Crit Rev Oncol Hematol. 2014 Mar;89(3):418-32
Authors: Sie M, den Dunnen WF, Hoving EW, de Bont ES
Abstract
B… Continue reading

Posted in Crit Rev Oncol Hematol | Leave a comment

Embryological signaling pathways in Barrett’s metaplasia development and malignant transformation; mechanisms and therapeutic opportunities.

Embryological signaling pathways in Barrett’s metaplasia development and malignant transformation; mechanisms and therapeutic opportunities.
Crit Rev Oncol Hematol. 2014 May 12;
Authors: Pavlov K, Meijer C, van den B… Continue reading

Posted in Crit Rev Oncol Hematol | Tagged , | Leave a comment

Recruitment of bone marrow derived cells during anti-angiogenic therapy in GBM: The potential of combination strategies.

Recruitment of bone marrow derived cells during anti-angiogenic therapy in GBM: The potential of combination strategies.
Crit Rev Oncol Hematol. 2014 May 10;
Authors: Boer JC, Walenkamp AM, Dunnen WF
Abstract… Continue reading

Posted in Crit Rev Oncol Hematol | Tagged , | Leave a comment

Turning promise into progress for antiangiogenic agents in epithelial ovarian cancer.

Related Articles
Turning promise into progress for antiangiogenic agents in epithelial ovarian cancer.
Crit Rev Oncol Hematol. 2012 Nov;84(2):224-42
Authors: van der Bilt AR, de Vries EG, de Jong S, Timmer-Bosscha H, van der Z… Continue reading

Posted in Crit Rev Oncol Hematol | Tagged , | Leave a comment

Malnutrition in childhood cancer patients: a review on its prevalence and possible causes.

Related Articles

Malnutrition in childhood cancer patients: a review on its prevalence and possible causes.

Crit Rev Oncol Hematol. 2012 Aug;83(2):249-75

Authors: Brinksma…

Continue reading

Posted in Crit Rev Oncol Hematol | Tagged | Leave a comment

Bortezomib and TRAIL: A perfect match for apoptotic elimination of tumour cells?

Related Articles

Bortezomib and TRAIL: A perfect match for apoptotic elimination of tumour cells?

Crit Rev Oncol Hematol. 2012 Aug 31;

Authors: de Wilt LH, Kroon J, Jansen…

Continue reading

Posted in Crit Rev Oncol Hematol | Tagged | Leave a comment

Tailored imaging of islet cell tumors of the pancreas amidst increasing options.

Related Articles

Tailored imaging of islet cell tumors of the pancreas amidst increasing options.

Crit Rev Oncol Hematol. 2012 May;82(2):213-26

Authors: Fiebrich HB, van…

Continue reading

Posted in Crit Rev Oncol Hematol | Tagged , | Leave a comment

Optimizing targeted cancer therapy: towards clinical application of systems biology approaches.

Related Articles

Optimizing targeted cancer therapy: towards clinical application of systems biology approaches.

Crit Rev Oncol Hematol. 2012 May;82(2):171-86

Authors: …

Continue reading

Posted in Crit Rev Oncol Hematol | Tagged , | Leave a comment

Perspectives for tailored chemoprevention and treatment of colorectal cancer in Lynch syndrome.

Perspectives for tailored chemoprevention and treatment of colorectal cancer in Lynch syndrome.

Crit Rev Oncol Hematol. 2011 Nov;80(2):264-77

Authors: Heijink DM, de Vries EG,…

Continue reading

Posted in Crit Rev Oncol Hematol | Tagged , | Leave a comment

The chemokine network, a newly discovered target in high grade gliomas.

The chemokine network, a newly discovered target in high grade gliomas.

Crit Rev Oncol Hematol. 2011 Aug;79(2):154-63

Authors: Domanska UM, Kruizinga RC, den Dunnen WF,…

Continue reading

Posted in Crit Rev Oncol Hematol | Tagged , | Leave a comment

The effect of under-treatment of breast cancer in women 80 years of age and older.

The effect of under-treatment of breast cancer in women 80 years of age and older.

Crit Rev Oncol Hematol. 2011 Sep;79(3):315-20

Authors: Van Leeuwen BL, Rosenkranz KM, Feng LL,…

Continue reading

Posted in Crit Rev Oncol Hematol | Tagged , | Leave a comment